Cervical/uterine procedure [Conization (any technique including LEEP, LLETZ etc.),Radical hysterectomy (including parametrectomy),Radical trachelectomy (including parametrectomy),Simple hysterectomy,Simple trachelectomy (cervix amputation without parametrectomy)]
Parametrectomy (applied for radical hysterectomy and radical trachelectomy)
Type [Nerve sparing,Not classified,Other,Simple hysterectomy,TMMR,Type A,Type B,Type C1,Type C2,Type D,Type II,Type III]
Description
Adnexal procedure
Type [Adnexal preservation,BSO,Previous BSO,Salpingectomy and ovarian preservation]
Extrapelvic transposition [No,Yes]
Surgical approach [Laparo-vaginal,Laparoscopic,Open (laparotomy),Robotic,Vaginal]
Lymph node staging
SLN biopsy
SLN biopsy was done [No,Yes]
Laterality [Bilat,Unilat]
Pelvic lymphadenectomy
Pelvic lymphadenectomy was performed [No,Yes]
Paraaortic lymphadenectomy
Paraaortic lymphadenectomy was performed [No,Yes]
Location
Inframesenterial (below arteria mesenterica inferior) [No,Yes]
Supramesenterial (up to the renal vessels) [No,Yes]
Final histological report
Cervix/Uterus
Size of the tumor
Largest tumor dimension (Sum of largest dimension of the specimen from therapeutic and diagnostic procedures)
LVSI [No,Yes]
Parametrial invasion
Parametrial invasion detected [No,Yes]
Laterality [Bilat,Unilat]
Free vaginal margins [No,Yes]
Final lymph node status
SLN [No,Yes]
No of SLN removed
No of SLN with metastases
SLN ultrastaging was performed [No,Yes]
Type of metastases (enter the largest type) [Isolated tumor cells,Macrometastases,Micrometastases]
Non-SLN pelvic LNs [No,Yes]
No of LN removed
No of LN with metastases
Type of metastases (enter the largest type) [Isolated tumor cells,Macrometastases,Micrometastases]
Size of the largest macrometastases
Paraaortic LNs (if PALD performed) [No,Yes]
No of LN removed
No of LN with metastases
Type of metastases (enter the largest type) [Isolated tumor cells,Macrometastases,Micrometastases]
Surgical data
Operation time
Blood loss
Surgical complication
Bowel injury [No,Yes]
Ureteral injury [No,Yes]
Urinary bladder injury [No,Yes]
Other [No,Yes]
Description
Serious early postoperative adverse-events ≥ 2 according to CTCAE grading (until 30th postoperative day)
1. adverse event [No,Yes]
Type [Blood,Gastrointestinal,Infections,Other,Renal,Respiratory,Skin,Surgical,Vascular]
Grade [2,3,4,5]
2. adverse event [No,Yes]
Type [Blood,Gastrointestinal,Infections,Other,Renal,Respiratory,Skin,Surgical,Vascular]
Grade [2,3,4,5]
3. adverse event [No,Yes]
Type [Blood,Gastrointestinal,Infections,Other,Renal,Respiratory,Skin,Surgical,Vascular]
Grade [2,3,4,5]
4. adverse event [No,Yes]
Type [Blood,Gastrointestinal,Infections,Other,Renal,Respiratory,Skin,Surgical,Vascular]
Grade [2,3,4,5]
5. adverse event [No,Yes]
Type [Blood,Gastrointestinal,Infections,Other,Renal,Respiratory,Skin,Surgical,Vascular]
Grade [2,3,4,5]
Type of primary treatment [Chemotherapy only,Other,Radiochemotherapy,Radiotherapy only]
Description of treatment
External beam radiotherapy [No,Yes]
Type [2D,3D,IMRT]
Machine [Cobalt source,Linear accelerator]
Area treated [Extended to paraaortic LN,Pelvis only]
Duration
Total dose
Number of fractions
Brachytherapy [No,Yes]
Type [High dose rate,Low dose rate,PDR]
Total dose
Number of fractions
Concomitant chemotherapy
Regimen
Carboplatin [No,Yes]
Dose per cycle
No of cycles [1,2,3,4,5]
Cisplatin [No,Yes]
Dose per cycle
No of cycles [1,2,3,4,5]
Other [No,Yes]
Description
Overall treatment (radiotherapy) time
Reason why concomitant chemotherapy was not applied
Impaired renal function [No,Yes]
Local standard [No,Yes]
Poor performance status [No,Yes]
Other [No,Yes]
Description
Regimen
Carboplatin [No,Yes]
Dose per cycle
No of cycles [1,2,3,4,5]
Cisplatin [No,Yes]
Dose per cycle
No of cycles [1,2,3,4,5]
Docetaxel [No,Yes]
Dose per cycle
No of cycles [1,2,3,4,5]
Paclitaxel [No,Yes]
Dose per cycle
No of cycles [1,2,3,4,5]
Topotecan [No,Yes]
Dose per cycle
No of cycles [1,2,3,4,5]
Other [No,Yes]
Description
Reason why radiotherapy was not given
Impaired renal function [No,Yes]
Local standard [No,Yes]
Poor performance status [No,Yes]
Other [No,Yes]
Description